Tag Archives: biopharmaceutical

What’s up Inhibitex, Pharmasset and Global Education & Technology?

Posted on November 21, 2011 by Martin Timble

In this report: Global Education & Technology (NASDAQ:GEDU), Pharmasset (NASDAQ:VRUS) and Inhibitex (NASDAQ:INHX).

Global Education & Technology (NASDAQ:GEDU) rallied by more than 97 percent on during early trading on Monday after it was reported that British publishing group Pearson Plc. would …

Posted in Latest Headlines, Reports | Tagged acquire, agreed, biopharmaceutical, cash, CEO, China, deal, drugs, GEDU, Gilead Sciences, Global Education & Technology, growth, healthcare, hepatitis C, Inhibitex, INHX, investors, NASDAQ, NASDAQ:GEDU, NASDAQ:INHX, NASDAQ:VRUS, Pearson, Pharmasset, premium, publishing group, report, sector, shares, takeover, trading, VRUS | Comments Off

Big time losers and the reasons why (CADX, SLXP, QEP)

Posted on November 14, 2011 by Martin Timble

In this report: QEP Resources (NYSE:QEP), Salix Pharmaceuticals (NASDAQ:SLXP) and Cadence Pharmaceuticals (NASDAQ:CADX).

QEP Resources (NYSE:QEP) has dropped by more than 6 percent today after the company said that it expects 2012 organic production growth of 12 to 14 percent, …

Posted in Latest Headlines, Reports | Tagged adjusted, Analysts, approval, biopharmaceutical, Cadence Pharmaceuticals, CADX, company, development, dilution, earnings, estimate, expects, Food and Drug Administration, market, meeting, NASDAQ, NASDAQ:CADX, NASDAQ:SLXP, NYSE, NYSE:QEP, positions, production growth, public stock, QEP, QEP Resources, regulators, Salix Pharmaceuticals, sell, shareholders, SLXP, sold off, stock offering, treatment, Xifaxan | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: biopharmaceutical

What’s up Inhibitex, Pharmasset and Global Education & Technology?

Big time losers and the reasons why (CADX, SLXP, QEP)

Follow us

Most Popular Posts

blogs